Thus, our analyses showed that NB is dependent on the glutathione, mevalonate, and thioredoxin pathways, and that higher activity of these pathways correlates with poor survival in NB patients, and chemotherapy resistance. The gene discussed is TXN; the disease is neuroblastoma.